Driehaus Capital Management LLC Cti Biopharma Corp Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $8.76 Million - $12.1 Million	1,633,541 New	1,633,541 $9.51 Million
Q3 2018 Nov 14, 2018	SELL	$1.72 - $5.24 $1.04 Million - $3.17 Million	-604,596 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.81 - $5.26 $92,773 - $128,081	24,350 Added 4.2%	604,596 $3.01 Million
Q1 2018 May 15, 2018	BUY	$2.7 - $4.06 $1.57 Million - $2.36 Million	580,246 New	580,246 $2.26 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.